The DOI matches its Crossref record; 224 of the 224 references it cites were found in a registry or an index.
Induced pluripotent stem cell technology: a decade of progress.
Open accessAbstract
Since the advent of induced pluripotent stem cell (iPSC) technology a decade ago, enormous progress has been made in stem cell biology and regenerative medicine. Human iPSCs have been widely used for disease modelling, drug discovery and cell therapy development. Novel pathological mechanisms have been elucidated, new drugs originating from iPSC screens are in the pipeline and the first clinical trial using human iPSC-derived products has been initiated. In particular, the combination of human iPSC technology with recent developments in gene editing and 3D organoids makes iPSC-based platforms even more powerful in each area of their application, including precision medicine. In this Review, we discuss the progress in applications of iPSC technology that are particularly relevant to drug discovery and regenerative medicine, and consider the remaining challenges and the emerging opportunities in the field.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In 2006, Takahashi and Yamanaka demonstrated that the expression of four transcription factors, OCT4, SOX2, KLF4, and c-MYC (collectively known as “OSKM”), reprograms the developmental potential of adult cells, enabling them to be converted into various cell types [17, 18].”
From Chemically induced reprogramming to reverse cellular aging (2023) · cites this paper as [18]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Self-citationInduction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Self-citationA Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Embryonic Stem Cell Lines Derived from Human Blastocysts
Thomson, J. A., Itskovitz‐Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S., & Jones, J. M. (1998) · Science · doi:10.1126/science.282.5391.1145 · Cited by 15,947
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A., & Liu, D. R. (2016) · Nature · doi:10.1038/nature17946 · Cited by 5,437
Cerebral organoids model human brain development and microcephaly
Lancaster, M. A., Renner, M., Martin, C.-A., Wenzel, D., Bicknell, L. S., Hurles, M. E., Homfray, T., Penninger, J. M., Jackson, A. P., & Knoblich, J. A. (2013) · Nature · doi:10.1038/nature12517 · Cited by 5,372
Genome-scale CRISPR-Cas9 knockout screening in human cells
Shalem, O., Sanjana, N. E., Hartenian, E., Shi, X., Scott, D. A., Mikkelsen, T. S., Heckl, D., Ebert, B. L., Root, D. E., Doench, J. G., et al. (2014) · Science · doi:10.1126/science.1247005 · Cited by 5,234
Flagged first, then by citations
Research works printed but not linked: 1
- Meissner, T., Strominger, J. & Cowan, C. The universal donor stem cells: removing the immune barrier to transplantation using CRISPR–Cas9. J. Immunol. 194 (1 Suppl.), 140.128 (2015).
Cited by
Sorted by citations
Items 901–1,000 of 1,001
Investigation of immune-related diseases using patient-derived induced pluripotent stem cells
Shoda, H., Natsumoto, B., & Fujio, K. (2023) · Inflammation and Regeneration · doi:10.1186/s41232-023-00303-4 · Cited by 6
Directed Differentiation of Neurons from Human iPSCs for Modeling Neurological Disorders
Wang, C., Cerneckis, J., & Shi, Y. (2024) · Methods in molecular biology · doi:10.1007/978-1-0716-3810-1_12 · Cited by 6
Self-citationTsai, H.-H. D., Ford, L. C., Burnett, S. D., Dickey, A. N., Wright, F. A., Chiu, W. A., & Rusyn, I. (2024) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.4c00193 · Cited by 7
Translating preclinical models of neuronal ceroid lipofuscinosis: progress and prospects
Nelvagal, H. R., & Cooper, J. D. (2017) · Expert Opinion on Orphan Drugs · doi:10.1080/21678707.2017.1360182 · Cited by 6
Recent Advances in Induced Pluripotent Stem Cell (iPSC) based Therapeutics
Verma, R. S. (2017) · Journal of Stem Cell Research & Therapeutics · doi:10.15406/jsrt.2017.03.00100 · Cited by 6
Honda, A. (2018) · BioEssays · doi:10.1002/bies.201700152 · Cited by 6
Gene Editing in Human Pluripotent Stem Cells: Recent Advances for Clinical Therapies
Şişli, H. B., Hayal, T. B., Seçkin, S., Şenkal, S., Kıratlı, B., Şahi̇n, F., & Doğan, A. (2019) · Advances in experimental medicine and biology · doi:10.1007/5584_2019_439 · Cited by 6
Cell sources and methods for producing organotypic in vitro human tissue models
Hayden, P. J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-817202-5.00002-4 · Cited by 8
Cai, M., Han, F., Xiong, N., Wang, Y., Feng, S., Wang, J., Li, X., Wei, J., & Sun, C. (2021) · Journal of Neurorestoratology · doi:10.26599/jnr.2021.9040005 · Cited by 6
Weinberg, R. S. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813726-0.00083-0 · Cited by 6
Rodríguez-Polo, I., & Behr, R. (2022) · Genes · doi:10.3390/genes13061093 · Cited by 8
Lucchino, V., Scaramuzzino, L., Scalise, S., Conte, M. L., Zannino, C., Benedetto, G. L., Aguglia, U., Ferlazzo, E., Cuda, G., & Parrotta, E. I. (2022) · Cells · doi:10.3390/cells11213491 · Cited by 5
Karimian, M., Nouri, N., Ghasemi, L. V., Mohammadi, A. H., & Behjati, M. (2023) · Tissue and Cell · doi:10.1016/j.tice.2023.102030 · Cited by 6
Activated KRAS reprograms neural progenitor cells to glioma stem cell‑like phenotype
Qin, Z., Liang, W., Zhang, Z., Li, P., Wang, T., Chen, Q., Guo, B., Zhong, Y., Kang, H., & Wang, L. (2023) · International Journal of Oncology · doi:10.3892/ijo.2023.5536 · Cited by 7
Halaidych, O. V., van den Hil, F. E., Mummery, C. L., & Orlova, V. V. (2018) · Journal of Visualized Experiments · doi:10.3791/58678 · Cited by 7
CD49f is a novel marker to purify functional human iPSC-derived astrocytesPreprint
Barbar, L., Jain, T., Zimmer, M., Kruglikov, I., Burstein, S. R., Rusielewicz, T., Nijsure, M. P., Croft, G. F., Wang, M., Zhang, B., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/678359 · Cited by 6
DNA binding redistributes activation domain ensemble and accessibility in pioneer factor Sox2Preprint
Bjarnason, S., McIvor, J. A. P., Prestel, A., Demény, K. S., Bullerjahn, J. T., Kragelund, B. B., Mercadante, D., & Heidarsson, P. O. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.06.16.545083 · Cited by 7
Gharandouq, M. H., Ismail, M. A., Saleh, T., Zihlif, M., & Ababneh, N. A. (2025) · Neurotoxicity Research · doi:10.1007/s12640-025-00734-6 · Cited by 5
Multi-organ model assessment of neurotoxicity following exposure of liver spheroids to drugs
Wu, W., Anas, F., Koc, B., Tian, L., Hasselkus, R., Rezania, D., Sharareh, S., Farberov, L., Zlotnik, D., Alon, A., et al. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118021 · Cited by 5
Naffaa, M. M. (2025) · Regenerative medicine reports . · doi:10.4103/regenmed.regenmed-d-25-00013 · Cited by 5
Hart, D. A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136250 · Cited by 5
Magnetically controlled microgelbots with stem cells for the treatment of interstitial cystitis
Choi, H., Kim, B., Seo, Y., Kim, T., Bong, K. W., & Hahn, S. K. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123551 · Cited by 6
Chang, M., Waldeck, J. B., Stephan, M., Kannaiyan, N. R., de Almeida, V., Boudriot, E., Karali, T., Röll, L., Fischer, L. E., Demetriou, D., et al. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03509-x · Cited by 6
Luo, Y., Xu, Z., & Li, Z. (2025) · FASEB BioAdvances · doi:10.1096/fba.2025-00126 · Cited by 5
Neurodegenerative disease and autophagy in iPSC-based models
Odonchimed, S., Imamura, K., & Inoue, H. (2025) · Neuroscience Research · doi:10.1016/j.neures.2025.104991 · Cited by 5
Self-citationPoking Pluripotency: Nanoinjection Into Human iPSCs
Harberts, J. I., Ho, V. T. T. X., Yang, Y., Jiang, Y., Elnathan, R., & Voelcker, N. H. (2026) · Advanced Materials · doi:10.1002/adma.202521046 · Cited by 5
Orzechowski, M., Schochow, M., Kühl, M., & Steger, F. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.627816 · Cited by 5
Li, R., Zhao, Y., Yourick, J. J., Sprando, R. L., & Gao, X. (2022) · Biomedical Reports · doi:10.3892/br.2022.1526 · Cited by 5
Biomaterial application strategies to enhance stem cell-based therapy for ischemic stroke
Satar, A. M., Othman, F. A., & Tan, S. C. (2022) · World Journal of Stem Cells · doi:10.4252/wjsc.v14.i12.851 · Cited by 5
Genome-engineering technologies for modeling and treatment of cystic fibrosis
Dębczyński, M., Mojsak, D., Minarowski, Ł., Maciejewska, M., Lisowski, P., & Mróz, R. M. (2023) · Advances in Medical Sciences · doi:10.1016/j.advms.2023.02.003 · Cited by 5
Gandhi, N. N., Wills, L. P., Akers, K., Su, Y., Niccum, P., Murali, T. M., & Rajagopalan, P. (2024) · Cell and Tissue Research · doi:10.1007/s00441-024-03868-9 · Cited by 5
Salimpour, Y., Anderson, W. S., Dastgheyb, R. M., Liu, S., Ming, G., Song, H., Maragakis, N. J., & Habela, C. W. (2024) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2024.110127 · Cited by 5
Chung, D.-J., Wang, C., Liu, P.-J., Ng, S.-K., Luo, C.-K., Jwo, S.-H., Li, C.-T., Hsu, D.-Y., Fan, C.-C., & Wei, T.-T. (2024) · Cancer Gene Therapy · doi:10.1038/s41417-024-00838-9 · Cited by 5
Mehmood, H., Kasher, P. R., Barrett‐Jolley, R., & Walmsley, G. (2024) · BMC Veterinary Research · doi:10.1186/s12917-024-04309-z · Cited by 11
Enrichment of Allelic Editing Outcomes by Prime Editing in Induced Pluripotent Stem Cells
Niwa, R., Matsumoto, T., Liu, A. Y., Kawato, M., Kondo, T., Tsukita, K., Gee, P., Inoue, H., Maurissen, T. L., & Woltjen, K. (2024) · The CRISPR Journal · doi:10.1089/crispr.2024.0028 · Cited by 5
Self-citationNakatsukasa, Y., Yamada, Y., & Yamada, Y. (2024) · Regenerative Therapy · doi:10.1016/j.reth.2024.11.008 · Cited by 8
Sustaining Brain Youth by Neural Stem Cells: Physiological and Therapeutic Perspectives
dos Santos, M. A., Moreira, J. A. F., Santos, S. S., & Solá, S. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04774-z · Cited by 7
Pluripotent Stem Cells: Recent Advances and Emerging Trends
Wang, A. Y. L., Aviña, A. E., Liu, Y., & Kao, H. (2025) · Biomedicines · doi:10.3390/biomedicines13040765 · Cited by 7
Excessive autophagic degradation of MYLK3 causes sunitinib-induced cardiotoxicity
Pan, Z., Zhu, L., Wang, X., Huangfu, N., Su, P., Yang, F., Fu, X., Pu, L., Fu, Q., Chen, J., et al. (2025) · Autophagy · doi:10.1080/15548627.2025.2524290 · Cited by 6
Geng, S., & Huang, Y. (2018) · Advanced Biosystems · doi:10.1002/adbi.201800099 · Cited by 5
Human induced pluripotent stem cells as a tool for disease modeling and drug screening for COVID-19
Nolasco, P., Borsoi, J., Moraes, C. B., Freitas-Junior, L. H., & Pereira, L. V. (2020) · Genetics and Molecular Biology · doi:10.1590/1678-4685-gmb-2020-0198 · Cited by 4
Fernandes, C. F. D. L., Coelho, B. P., Souza, M. C. D. S., Boccacino, J. M., Soares, S. R., de Araújo, J. P. A., Melo-Escobar, M. I., & Lopes, M. H. (2022) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2022.05.027 · Cited by 6
Role of Chaperone-Mediated Autophagy in Ageing Biology and Rejuvenation of Stem Cells
Vitale, E., Perveen, S., Rossin, D., Iacono, M. L., Rastaldo, R., & Giachino, C. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.912470 · Cited by 6
Transforming one organ into another to overcome challenges in tissue engineering
Wang, Z., Tian, X., Wang, C., Qi, X., Gracia‐Sancho, J., & Dong, L. (2022) · Portal hypertension & cirrhosis · doi:10.1002/poh2.26 · Cited by 5
Ng, W.-C., Lokanathan, Y., Baki, M. M., Fauzi, M. B., Zainuddin, A. A., & Azman, M. B. (2022) · Biomedicines · doi:10.3390/biomedicines10123082 · Cited by 5
Ali, H. R. W., Suliman, S., Osman, T., Carrasco, M., Bruland, O., Costea, D. E., Ræder, H., & Mustafa, K. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03403-7 · Cited by 5
Equine Induced Pluripotent Stem Cell Culture
Falk, J., & Donadeu, F. X. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-3609-1_16 · Cited by 5
Dagher, R., Moldobaeva, A., Gubbins, E., Clark, S., Alfajaro, M. M., Wilen, C. B., Hawkins, F. J., Qu, X., Chiang, C.-C., Li, Y., et al. (2024) · Stem Cells · doi:10.1093/stmcls/sxad094 · Cited by 5
Bouguechtouli, C., Ghouil, R., Alik, A., Dingli, F., Loew, D., & Theillet, F. (2024) · Comptes Rendus Chimie · doi:10.5802/crchim.272 · Cited by 5
Synthetic human gonadal tissues for toxicology
Nishimura, T., & Takebe, T. (2024) · Reproductive Toxicology · doi:10.1016/j.reprotox.2024.108598 · Cited by 6
Desa, D. E., Amitrano, M. J., Murphy, W. L., & Skala, M. C. (2024) · Biophotonics discovery. · doi:10.1117/1.bios.1.1.015002 · Cited by 5
Bingnan, W., Jiao, T., Ghorbani, A., & Baghei, S. (2024) · Tissue and Cell · doi:10.1016/j.tice.2024.102429 · Cited by 6
Budi, N. Y. P., Lai, W.-Y., Huang, Y., & Ho, H. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1361084 · Cited by 5
iPSC-Derived Cardiomyocytes as a Disease Model to Understand the Biology of Congenital Heart Defects
Pushpan, C. K., & Kumar, S. R. (2024) · Cells · doi:10.3390/cells13171430 · Cited by 6
Hameed, S. S., & Sharma, T. P. (2025) · Current Protocols · doi:10.1002/cpz1.70091 · Cited by 5
Lobo, S., Barbosa‐Matos, R., Dória, S., Pedro, A. M., Brito, A., Ferreira, D. A., & Oliveíra, C. (2025) · Biology Methods and Protocols · doi:10.1093/biomethods/bpaf018 · Cited by 4
Fujibayashi, E., Yabuta, N., Nishikawa, Y., Uchihashi, T., Miura, D., Kurioka, K., Tanaka, S., Kogo, M., & Nojima, H. (2018) · Oncotarget · doi:10.18632/oncotarget.26092 · Cited by 5
A Japanese Bioventure Company's Application of Stem Cell Technology in Regenerative Medicine
Sawada, M., Sugiyama, D., Nii, T., Konno, K., & Kagimoto, H. T. S. (2018) · Clinical Therapeutics · doi:10.1016/j.clinthera.2018.10.001 · Cited by 5
Collo, G., Cavalleri, L., & Pich, E. M. (2019) · Chronic Stress · doi:10.1177/2470547019842545 · Cited by 5
Quantitative analysis of operators’ flow line in the cell culture for controlled manual operation
Kanie, K., Sasaki, H., Ikeda, Y., Tamada, M., Togawa, F., & Kato, R. (2019) · Regenerative Therapy · doi:10.1016/j.reth.2019.04.008 · Cited by 5
Qiu, H., Qian, T., Wu, T., Wang, X., Zhu, C., Chen, C., & Wang, L. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24751 · Cited by 5
Cellular reprogramming: Mathematics meets medicine
Dotson, G. A., Ryan, C. W., Chen, C., Muir, L. A., & Rajapakse, I. (2020) · WIREs Mechanisms of Disease · doi:10.1002/wsbm.1515 · Cited by 4
Translational potential of hiPSCs in predictive modeling of heart development and disease
Mansfield, C., Zhao, M., & Basu, M. (2022) · Birth Defects Research · doi:10.1002/bdr2.1999 · Cited by 6
Advancing Engineered Heart Muscle Tissue Complexity with Hydrogel Composites
Dickerson, D. A. (2022) · Advanced Biology · doi:10.1002/adbi.202200067 · Cited by 5
Kojima, R., Pasławski, W., Lyu, G., Arenas, E., Zhang, X., & Svenningsson, P. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25010683 · Cited by 5
Paerwen, P., Itô, A., Yoshioka, K., Kaori, I., Fujiwara, S., Horie, M., Kawabe, Y., & Kamihira, M. (2018) · Journal of Bioscience and Bioengineering · doi:10.1016/j.jbiosc.2018.10.009 · Cited by 5
Caporale, N., & Testa, G. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814879-2.00017-0 · Cited by 5
Shrestha, R. (2020) · Progress in Stem Cell · doi:10.15419/psc.v7i1.409 · Cited by 5
Improving the safety of iPSC-derived T cell therapy
Ando, M., Kinoshita, S., Furukawa, Y., Ando, J., Nakauchi, H., & Brenner, M. (2022) · Molecular Players in iPSC Technology · doi:10.1016/b978-0-323-90059-1.00010-5 · Cited by 3
Multimodal foundation model predicts zero-shot functional perturbations and cell fate dynamicsPreprint
Yang, Z., Fan, X., Lan, M., Tang, X., Zheng, Z., Liu, B., You, Y., Tian, L., Church, G. M., Liu, X., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.12.19.629561 · Cited by 5
Bell, M., & Krasnodembskaya, A. D. (2025) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szaf040 · Cited by 4
Quantifying HiPSC-CM structural organization at scale with deep learning-enhanced SarcGraph
Mohammadzadeh, S., & Lejeune, E. (2025) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1013436 · Cited by 5
Giri, S., & Rajesh, P. (2026) · Biomedicines · doi:10.3390/biomedicines14020485 · Cited by 5
Li, J., Chaurasiya, S., Sun, G., Cui, Q., Ye, P., Qin, Y., Zhou, T., Wang, X., Fong, Y., Maus, M. V., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-71021-x · Cited by 4
Self-citationDecoding Liver Fibrosis: How Omics Technologies and Innovative Modeling Can Guide Precision Medicine
Codotto, G., Blarasin, B., Tiribelli, C., Bellarosa, C., & Licastro, D. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26062658 · Cited by 6
Du, B., Dai, Z., Wang, H., Ren, Z., & Li, D. (2025) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm26697 · Cited by 5
Wang, J., Huang, S., Li, K., Li, J., & Huang, X. Y. (2025) · Regenerative Therapy · doi:10.1016/j.reth.2025.06.015 · Cited by 5
Rodschinka, G., Forcelloni, S., Kühner, F. M., Wani, S., Riemenschneider, H., Edbauer, D., Behrens, A., & Nedialkova, D. D. (2025) · Nature Structural & Molecular Biology · doi:10.1038/s41594-025-01616-3 · Cited by 4
Tanaka, E., Kishikawa, T., Miyakawa, Y., Shibata, C., Notoya, G., Yasugi, K., Seimiya, T., Otsuka, M., & Fujishiro, M. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.152547 · Cited by 4
Kearney, H., Rak‐Raszewska, A., Seijas‐Gamardo, A., Escarda‐Castro, E., Caiment, F., Wieringa, P. A., Moroni, L., & Mota, C. (2025) · Stem Cell Reviews and Reports · doi:10.1007/s12015-025-10971-z · Cited by 4
Kuwata, F., Ohnishi, H., Yamamoto, N., Takezawa, T., Yamashita, M., Okuyama, H., Hayashi, Y., Yoshimatsu, M., Kitada, Y., Tada, T., et al. (2021) · Tissue Engineering Part A · doi:10.1089/ten.tea.2021.0071 · Cited by 4
Ye, Z., Chen, G., Hou, C., Jiang, Z., Wang, E., & Wang, J. (2022) · Cell Biology International · doi:10.1002/cbin.11858 · Cited by 4
Direct Reprogramming in Bone and Joint Degenerative Diseases: Applications, Obstacles and Directions
Shi, K., Li, F., Tao, Y., & Chen, Q. (2022) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x17666220810142943 · Cited by 3
The CRISPR Revolution: Unraveling the mysteries of Life’s genetic code
Harsij, Z., Ghafoorzadeh, Z., & Goharian, E. (2023) · Gene · doi:10.1016/j.gene.2023.147870 · Cited by 5
Boumelhem, B. B., Fraser, S. T., Farajikhah, S., Shparberg, R. A., Morris, M. B., Bilek, M., Zhang, A., Akhavan, B., Fleming, S., & Large, M. C. J. (2023) · Engineered Regeneration · doi:10.1016/j.engreg.2023.12.003 · Cited by 4
Munezane, H., Imamura, K., Fujimoto, N., Hotta, A., Yukitake, H., & Inoue, H. (2024) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2024.151446 · Cited by 5
Self-citationLu, X., Perr, E., Naqvi, T., Galitz, D., Andersen, M., Grabowski, D. C., Person, A. D., Kalyuzhny, A. E., & Flynn, K. C. (2024) · Cells · doi:10.3390/cells13181566 · Cited by 4
Balogh, A., Bódi-Jakus, M., Karl, V. R., Bellák, T., Széky, B., Farkas, J., Lamberto, F., Novak, D., Fehér, A., Zana, M., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-72791-4 · Cited by 4
Шевелева, О. Н., Protasova, E., Grigor’eva, E. V., Butorina, N. N., Kuziaeva, V. I., Antonov, D., Melnikova, V. I., Medvedev, S. P., & Lyadova, I. V. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212456 · Cited by 4
Human pluripotent stem cell (hPSC)-derived models for autism spectrum disorder drug discovery
Nie, L., Irwin, C. L., Geahchan, S., & Singh, K. K. (2024) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2024.2416484 · Cited by 4
Kim, H.-G., Lee, B.-N., Jeong, H., Kim, H., Kwon, J., Oh, S., Kim, D.-S., Choi, K., Kim, R. H., & Jang, J. (2025) · Biomaterials Research · doi:10.34133/bmr.0142 · Cited by 4
Mahmoud, M. B., Rátkai, A. E., Bauer, K., Bencsik, N., Szűcs, A. L., Schlett, K., & Tárnok, K. (2025) · Scientific Reports · doi:10.1038/s41598-024-81140-4 · Cited by 4
Ye, J., Boileau, R. M., Parchem, R. J., Judson‐Torres, R. L., & Blelloch, R. H. (2025) · Stem Cells · doi:10.1093/stmcls/sxae080 · Cited by 4
Nandal, A., Mallon, B. S., & Telugu, B. P. V. L. (2017) · Journal of Visualized Experiments · doi:10.3791/56260 · Cited by 4
Bourque, K., Jones-Tabah, J., Mnasri, N., Martin, R., & Hébert, T. E. (2018) · Biomolecules · doi:10.3390/biom8040180 · Cited by 5
Expanding the Differentiation Potential of Already-Established Pluripotent Stem Cells
González‐Martínez, J., & Malumbres, M. (2021) · Methods in molecular biology · doi:10.1007/7651_2021_408 · Cited by 4
Santos, R. D. S., Gross, A. R., & Sareen, D. (2021) · Handbook of Clinical Neurology · doi:10.1016/b978-0-12-820683-6.00025-7 · Cited by 2
Models of kidney glomerulus derived from human-induced pluripotent stem cells
Okafor, A. E., Bhattacharya, R., & Musah, S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823809-7.00013-x · Cited by 3
CRISPR-Cas Gene Perturbation and Editing in Human Induced Pluripotent Stem Cells
van Essen, M. J., Riepsaame, J., & Jacob, J. (2021) · The CRISPR Journal · doi:10.1089/crispr.2021.0063 · Cited by 4
Endogenous tagging using split mNeonGreen in human iPSCs for live imaging studies
Husser, M. C., Pham, N. P., Law, C., Araujo, F. R., Martin, V. J., & Piekny, A. (2024) · eLife · doi:10.7554/elife.92819 · Cited by 2
Metadata
- Authors
- Shi, Y., Inoue, H., Wu, J. C., & Yamanaka, S.
- Affiliations
- City Of Hope National Medical Center (US)
- Kyoto University (JP)
- Stanford Cardiovascular Institute (US)
- Gladstone Institutes (US)
- Corresponding author
- Shi, Yanhong
- Inoue, Haruhisa
- Venue
- Nature Reviews Drug Discovery
- Published
- 2016-12-16
- Volume
- 16
- Issue
- 2
- Pages
- 115-130
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- PMC
- PMC6416143
- OpenAlex
- W2565787913
- Cited by
- 1,525
- References
- 224
- Citations by year
- 2026: 96 · 2025: 143 · 2024: 177 · 2023: 185 · 2022: 194 · 2021: 205 · 2020: 199 · 2019: 123 · 2018: 143 · 2017: 56 · 2016: 1
- FWCI
- 9.72
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Heart, Lung, and Blood Institute (R01HL128170, R01HL130020)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Keywords
- induced pluripotent stem cells, drug discovery, regenerative medicine, disease modeling, cell therapy, genome editing, 3D organoids, precision medicine, clinical trials
- MeSH terms
- Drug Therapy, Humans, Stem Cell Transplantation, Regenerative Medicine, History, 21st Century, Drug Discovery, Induced Pluripotent Stem Cells, High-Throughput Screening Assays
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
